PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
50.26%
Some net income increase while TSM is negative at -13.59%. John Neff would see a short-term edge over the struggling competitor.
-2.99%
Negative yoy D&A while TSM is 50.50%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1314.75%
Well above TSM's 1.47% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
86.58%
Some inventory rise while TSM is negative at -14097.99%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
315.78%
Growth well above TSM's 52.43%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
2945.57%
Well above TSM's 498.87%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
168.00%
Operating cash flow growth above 1.5x TSM's 14.94%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-74.11%
Negative yoy CapEx while TSM is 32.09%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-215.36%
Both yoy lines negative, with TSM at -91.97%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
77.43%
At 50-75% of TSM's 148.62%. Martin Whitman questions partial disadvantage if competitor monetizes investments more efficiently.
-25.27%
Both yoy lines negative, with TSM at -1275.42%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-136.65%
We reduce yoy invests while TSM stands at 16.84%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-54.84%
Negative yoy issuance while TSM is 45.49%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-25.00%
We cut yoy buybacks while TSM is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.